| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6500456 | VIATRIS | Compressed nitroglycerin tablet and its method of manufacture |
Sep, 2018
(5 years ago) | |
Nitrostat is owned by Viatris.
Nitrostat contains Nitroglycerin.
Nitrostat has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Nitrostat are:
- US6500456
Nitrostat was authorised for market use on 01 May, 2000.
Nitrostat is available in tablet;sublingual dosage forms.
The generics of Nitrostat are possible to be released after 16 September, 2018.
Drugs and Companies using NITROGLYCERIN ingredient
Market Authorisation Date: 01 May, 2000
Treatment: NA
Dosage: TABLET;SUBLINGUAL
How can I launch a generic of NITROSTAT before it's drug patent expiration?
More Information on Dosage
NITROSTAT family patents
